Downregulation of miR‑429 and inhibition of cell migration and invasion in nasopharyngeal carcinoma

Wang,Fangzheng; Jiang,Chuner; Sun,Quanquan; Yan,Fenqin; Wang,Lei; Fu,Zhenfu; Liu,Tongxin; Hu,Fujun

doi:10.3892/mmr.2016.4940

Downregulation of miR‑429 and inhibition of cell migration and invasion in nasopharyngeal carcinoma

Authors:
- Fangzheng Wang
- Chuner Jiang
- Quanquan Sun
- Fenqin Yan
- Lei Wang
- Zhenfu Fu
- Tongxin Liu
- Fujun Hu
View Affiliations

Affiliations: Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China, Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China
Published online on: February 23, 2016 https://doi.org/10.3892/mmr.2016.4940
Pages: 3236-3242

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Viral, dietary and genetic factors have been implicated in nasopharyngeal carcinoma (NPC), however, the molecular mechanism underlying its pathogenesis remains to be fully elucidated. MicroRNAs (miRNAs) have been reported to be important in NPC tumorigenesis, with a previous miRNA microarray study showing the downregulation of miRNA (miR)‑429 in NPC cells. However, the possible mechanisms of action of miR‑429 have not been examined. In the present study, the expression profiles of miR‑429 were detected using reverse transcription‑quantitative polymerase chain reaction analysis in CNE‑1 and CNE‑2 cells, which are two generally used NPC cells with different degrees of differentiation. Subsequently, cell proliferation, invasion and migration were analyzed in miR‑429‑overexpressing CNE‑2 cells, and the modulatory function of miR‑429 was also investigated using two target genes, zinc finger E‑Box‑binding homeobox 1 (ZEB1) and CRK‑like (CRKL), by transfection with miR‑429 mimic or anti‑miR‑429. Significant changes in the expression of miR‑429 were detected, particularly in low‑differentiated CNE‑2 cells, with higher levels of epidemicity and malignancy. Additional results revealed that miR‑429 inhibited the invasion and migration of the CNE‑2 cells, whereas no significant effect on cell growth was observed. In addition, the mRNA and protein expression levels of the two target genes, ZEB1 and CRKL, were negatively regulated by miR‑429, demonstrated through gain‑of‑function and loss‑of‑function investigations, indicating that these two functional downstream targets may be involved in the inhibitory effects of miR‑429 on NPC migration and invasion. miR‑429 may act as a negative regulatory factor of NPC tumorigenesis, involving the functions of its downstream targets, ZEB1 and CRKL. The results suggested miR‑429 as a potential candidate for miRNA‑based prognosis or therapy against NPC.

View Figures

View References

1	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
2	Schirle NT, Sheu-Gruttadauria J and MacRae IJ: Structural basis for microRNA targeting. Science. 346:608–613. 2014. View Article : Google Scholar : PubMed/NCBI
3	Lu J, Getz G, Miska EA, Alvarez Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
4	Xie YJ, Long ZF and He XS: Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in naso-pharyngeal carcinoma genesis. Asian Pac J Cancer Prev. 14:5637–5644. 2013. View Article : Google Scholar
5	Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL and Ragoussis J: microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res. 71:5635–5645. 2011. View Article : Google Scholar : PubMed/NCBI
6	Bojmar L, Karlsson E, Ellegård S, Olsson H, Björnsson B, Hallböök O, Larsson M, Stål O and Sandström P: The role of microRNA-200 in progression of human colorectal and breast cancer. PloS One. 8:e848152013. View Article : Google Scholar :
7	Baranwal S and Alahari SK: miRNA control of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290. 2010.
8	Brennan B: Nasopharyngeal carcinoma. Orphanet J Rare Dis. 1:232006. View Article : Google Scholar : PubMed/NCBI
9	Lo KW, To KF and Huang DP: Focus on nasopharyngeal carcinoma. Cancer Cell. 5:423–428. 2004. View Article : Google Scholar : PubMed/NCBI
10	Lung ML: Unlocking the rosetta stone enigma for naso-pharyngeal carcinoma: Genetics, viral infection and epidemiological factors. Semin Cancer Biol. 22:77–78. 2012. View Article : Google Scholar : PubMed/NCBI
11	Nor Hashim NA, Ramzi NH, Velapasamy S, Alex L, Chahil JK, Lye SH, Munretnam K, Haron MR and Ler LW: Identification of genetic and non-genetic risk factors for naso-pharyngeal carcinoma in a Southeast Asian population. Asian Pac J Cancer Prev. 13:6005–6010. 2012. View Article : Google Scholar
12	Hildesheim A and Wang CP: Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000–2011: Rosetta Stone for NPC: Genetics, viral infection and other environmental factors. Semin Cancer Biol. 22:107–116. 2012. View Article : Google Scholar : PubMed/NCBI
13	Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, et al: Prognostic value of a microRNA signature in nasopharyngeal carcinoma: A microRNA expression analysis. Lancet Oncol. 13:633–641. 2012. View Article : Google Scholar : PubMed/NCBI
14	Yu BL, Peng XH, Zhao FP, Liu X, Lu J, Wang L, Li G, Chen HH and Li XP: MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression. Int J Oncol. 44:1215–1222. 2014.PubMed/NCBI
15	Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
16	Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun. 391:535–541. 2010. View Article : Google Scholar
17	Sun XJ, Liu H, Zhang P, Zhang XD, Jiang ZW and Jiang CC: miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev. 14:5533–5537. 2013. View Article : Google Scholar : PubMed/NCBI
18	Luo Z, Zhang L, Li Z, Li X and Li G, Yu H, Jiang C, Dai Y, Guo X, Xiang J and Li G: An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of naso-pharyngeal carcinoma. BMC Med Genomics. 5:32012. View Article : Google Scholar
19	Chen J, Wang L, Matyunina LV, Hill CG and McDonald JF: Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol Oncol. 121:200–205. 2011. View Article : Google Scholar : PubMed/NCBI
20	Zhu W, He J, Chen D, Zhang B, Xu L, Ma H, Liu X, Zhang Y and Le H: Expression of miR-29c, miR-93 and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PloS One. 9:e877802014. View Article : Google Scholar
21	Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu Z, Li X and Wu M: MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma. Mol Cell Biochem. 390:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
22	Ye ZB, Ma G, Zhao YH, Xiao Y, Zhan Y, Jing C, Gao K, Liu ZH and Yu SJ: miR-429 inhibits migration and invasion of breast cancer cells in vitro. Int J Oncol. 46:531–538. 2015.
23	Zhang S, Wu Y, Zeng Y, Zech L and Klein G: Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. Hereditas. 97:23–28. 1982. View Article : Google Scholar : PubMed/NCBI
24	Sizhong Z, Xiukung G and Yi Z: Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int J Cancer. 31:587–590. 1983. View Article : Google Scholar : PubMed/NCBI
25	Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, Wong N, Yuen PW, Lo AK, Wong YC and Huang DP: Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta. 1590:150–158. 2002. View Article : Google Scholar : PubMed/NCBI
26	Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
27	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
28	Tsang WP and Kwok TT: The miR-18a^* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis. 30:953–959. 2009. View Article : Google Scholar : PubMed/NCBI
29	Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K, Wu M, Liang Y, Liu P, Tang J, et al: MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle. 11:2495–2506. 2012. View Article : Google Scholar : PubMed/NCBI
30	Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
31	Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002. View Article : Google Scholar : PubMed/NCBI
32	Chou J, Lin YC, Kim J, You L, Xu Z, He B and Jablons DM: Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck. 30:946–963. 2008. View Article : Google Scholar : PubMed/NCBI
33	Lee AW, Foo W, Law SC, Poon YF, Sze WM, O SK, Tung SY and Lau WH: Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J. 3:355–361. 1997.
34	Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W, Li X, Fan S, Cao L, Tang K, Wu M and Li G: Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol. 133:71–81. 2007. View Article : Google Scholar
35	Li G, Liu Y, Su Z, Ren S, Zhu G, Tian Y and Qiu Y: MicroRNA-324–3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur J Cancer. 49:2596–2607. 2013. View Article : Google Scholar : PubMed/NCBI
36	Lu J, Xu X, Liu X, Peng Y, Zhang B, Wang L, Luo H, Peng X, Li G, Tian W, et al: Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. Br J Cancer. 110:392–398. 2014. View Article : Google Scholar :
37	Korpal M and Kang Y: The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 5:115–119. 2008. View Article : Google Scholar
38	Wang Y, Li M, Zang W, Ma Y, Wang N, Li P, Wang T and Zhao G: MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol (Dordr). 36:385–394. 2013. View Article : Google Scholar
39	Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H and Foisner R: DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
40	Senechal K, Halpern J and Sawyers CL: The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene. J Biol Chem. 271:23255–23261. 1996. View Article : Google Scholar : PubMed/NCBI